Literature DB >> 22879076

Abnormal glucose and lipid control in non-ischemic left ventricular dysfunction.

Danilo Neglia1, Tiziana Sampietro, Cecilia Vecoli, Riccardo Liga, Giuseppe Rossi, Elena Filidei, Federico Bigazzi, Patricia Iozzo, Daniela Giannessi, Antonio L'Abbate, Daniele Rovai.   

Abstract

BACKGROUND: Cardiovascular risk factors are classically associated with coronary atherosclerosis. We sought to investigate whether risk factors are also associated with left ventricular (LV) dilatation, contractile impairment and reduced myocardial blood flow (MBF) in patients with non-ischemic LV dysfunction.
METHODS: We studied 81 patients (59 males, age 60 ± 9 years) with mild-to-severe LV dysfunction (mean ejection fraction 37%, range 19%-50%), no history of diabetes and normal coronary arteries. Absolute MBF was measured by positron emission tomography and (13)N-ammonia at rest and after dipyridamole (0.56 mg/kg I.V. over 4 min).
RESULTS: Overt LV dysfunction (LV end-diastolic diameter >60 mm associated with LV ejection fraction <45%) was present in 42 patients (52%); severely depressed hyperemic MBF (<1.09 mL · min(-1) · g(-1)) was present in 41 patients (51%). Using multivariate logistic regression analysis, low high-density lipoprotein cholesterol (HDL-C, P < .036), newly diagnosed non-insulin-dependent diabetes or insulin-resistance (NIDD/IR, P < .019) and the use of diuretics (P = .001) were independently associated with overt LV dysfunction. Low HDL-C (P = .015) and NIDD/IR (P = .048) were also independently associated with severely depressed hyperemic MBF.
CONCLUSIONS: Low HDL-C and NIDD/IR are associated with more severe LV impairment and reduced hyperemic MBF in non-ischemic LV dysfunction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22879076     DOI: 10.1007/s12350-012-9609-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  27 in total

1.  Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography.

Authors:  K L Gould; Y Nakagawa; K Nakagawa; S Sdringola; M J Hess; M Haynie; N Parker; N Mullani; R Kirkeeide
Journal:  Circulation       Date:  2000-04-25       Impact factor: 29.690

2.  Physiological basis for angina and ST-segment change PET-verified thresholds of quantitative stress myocardial perfusion and coronary flow reserve.

Authors:  Nils P Johnson; K Lance Gould
Journal:  JACC Cardiovasc Imaging       Date:  2011-09

3.  Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.

Authors:  Estelle Nobécourt; Fatiha Tabet; Gilles Lambert; Rajesh Puranik; Shisan Bao; Ling Yan; Michael J Davies; Bronwyn E Brown; Alicia J Jenkins; Gregory J Dusting; David J Bonnet; Linda K Curtiss; Philip J Barter; Kerry-Anne Rye
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01-28       Impact factor: 8.311

4.  Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy.

Authors:  Danilo Neglia; Renata De Maria; Stefano Masi; Michela Gallopin; Patrizia Pisani; Silvia Pardini; Antonello Gavazzi; Antonio L'abbate; Oberdan Parodi
Journal:  Heart       Date:  2007-01-19       Impact factor: 5.994

5.  Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans.

Authors:  P Chareonthaitawee; P A Kaufmann; O Rimoldi; P G Camici
Journal:  Cardiovasc Res       Date:  2001-04       Impact factor: 10.787

Review 6.  Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

Authors:  Jeong-a Kim; Monica Montagnani; Kwang Kon Koh; Michael J Quon
Journal:  Circulation       Date:  2006-04-18       Impact factor: 29.690

7.  Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy.

Authors:  Sophie Van Linthout; Frank Spillmann; Alexander Riad; Christiane Trimpert; Joke Lievens; Marco Meloni; Felicitas Escher; Elena Filenberg; Okan Demir; Jun Li; Mehdi Shakibaei; Ingolf Schimke; Alexander Staudt; Stephan B Felix; Heinz-Peter Schultheiss; Bart De Geest; Carsten Tschöpe
Journal:  Circulation       Date:  2008-03-10       Impact factor: 29.690

8.  Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy.

Authors:  Eleftheria P Tsagalou; Maria Anastasiou-Nana; Emmanuel Agapitos; Apostolia Gika; Stavros G Drakos; John V Terrovitis; Argirios Ntalianis; John N Nanas
Journal:  J Am Coll Cardiol       Date:  2008-10-21       Impact factor: 24.094

9.  The prognostic impact of coronary flow-reserve assessed by Doppler echocardiography in non-ischaemic dilated cardiomyopathy.

Authors:  Fausto Rigo; Sonia Gherardi; Maurizio Galderisi; Lorenza Pratali; Lauro Cortigiani; Rosa Sicari; Eugenio Picano
Journal:  Eur Heart J       Date:  2006-02-07       Impact factor: 29.983

10.  Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy.

Authors:  C B Treasure; J A Vita; D A Cox; R D Fish; J B Gordon; G H Mudge; W S Colucci; M G Sutton; A P Selwyn; R W Alexander
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

View more
  3 in total

1.  Insulin resistance is a major determinant of myocardial blood flow impairment in anginal patients.

Authors:  Riccardo Liga; Daniele Rovai; Tiziana Sampietro; Cecilia Vecoli; Giancarlo Todiere; Chiara Caselli; Giuseppe Rossi; Antonio L'abbate; Danilo Neglia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-11       Impact factor: 9.236

2.  Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure.

Authors:  Federico Bigazzi; Maria Pia Adorni; Mariarita Puntoni; Francesco Sbrana; Vincenzo Lionetti; Beatrice Dal Pino; Elda Favari; Fabio A Recchia; Franco Bernini; Tiziana Sampietro
Journal:  J Atheroscler Thromb       Date:  2016-12-15       Impact factor: 4.928

3.  Elevated Glucose Oxidation, Reduced Insulin Secretion, and a Fatty Heart May Be Protective Adaptions in Ischemic CAD.

Authors:  J C Hannukainen; R Lautamäki; A Mari; J P Pärkkä; M Bucci; M A Guzzardi; S Kajander; T Tuokkola; J Knuuti; P Iozzo
Journal:  J Clin Endocrinol Metab       Date:  2016-04-05       Impact factor: 5.958

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.